Affiliations: INSERM E 0226, Faculté de Medecine Lyon Nord, Université Claude Bernard, Lyon, France | Cell Therapy Department, EFS Rhone‐Alpes, Lyon, France | Hematology Department, Debrousse Hospital, Lyon, France
Note: [] Corresponding author: Dr Assia Eljaafari, Unite de Therapie Cellulaire el Tissus, CHU Brabois, Rue Morvan, 54511 Vandœuvre les Nancy, France. E‐mail: [email protected]‐nancy.fr.
Abstract: Mesenchymal stem cells (MSC) fail to induce allogeneic responses in mixed lymphocyte reaction assays. Because MSC express HLA class I molecules, here we investaged whether they could be recognized as allogeneic targets by cytolytic T lymphocytes (CTL). With this aim, CTL precursor (CTLp) frequencies were measured following stimulation of T cells with either allogeneic mononuclear cells (MNC) or MSC originated from the same human bone marrow donor. Lysis of MSC was measured at day 10 of culture in standard chromium release assays. In addition, allogeneic PHA blast T cells or B‐EBV lymphoblastoid cell lines (LCLs) generated from the same donor were used as positive controls of lysis. Our results showed that when allogeneic MNC were used to stimulate T cells, a high CTLp frequency was detected towards MSC targets. However, when MSC were used as stimulators, CTLp frequencies were markedly altered whatever the targets used, i.e.: MSC, PHA blast T cells or EBV‐B LCLs. Moreover, when graded concentrations of MSC were added together with MNC upon stimulation of alloreactive T cells, we observed a dose‐dependent decrease in CTLp frequencies towards MSC targets. This inhibition of MSC lysis was partially overcomed by adding exogenous rh‐IL‐2 from the beginning of cultures. In addition, this suppressive effect was totally reproduced when, instead of MSC, supernatant harvested from MSC cultures was added to allogeneic MNC, upon stimulation of alloreactive T cells. In conclusion, our results demonstrate that MSC which can be recognized as targets by pre‐activated alloreactive CTLs, may be able to suppress differentiation of CTL precursors into CTL effectors through secretion of suppressive factors.
Journal: Biorheology, vol. 41, no. 3‐4, pp. 469-476, 2004
